Mar 31, 2013

United Therapeutics Q1 2013 Earnings Report

Total Revenue
$245M
Previous year: $204M
+20.0%
EPS
$2.46
Previous year: $1.32
+86.4%
Gross Profit
$216M
Previous year: $180M
+19.8%
Cash and Equivalents
$262M
Previous year: $157M
+67.3%
Total Assets
$1.7B
Previous year: $1.56B
+8.7%

United Therapeutics

United Therapeutics